Interleukin-5 and eosinophils as therapeutic targets for asthma
- 1 April 2002
- journal article
- opinion
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 8 (4) , 162-167
- https://doi.org/10.1016/s1471-4914(02)02302-x
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The trials and tribulations of IL-5, eosinophils, and allergic asthmaJournal of Allergy and Clinical Immunology, 2001
- Murine model of chronic human asthmaImmunology & Cell Biology, 2001
- Therapeutic efficacy of an anti–IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthmaPublished by Elsevier ,1999
- IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESSAnnual Review of Immunology, 1999
- IL-5-Deficient Mice Have a Developmental Defect in CD5+ B-1 Cells and Lack Eosinophilia but Have Normal Antibody and Cytotoxic T Cell ResponsesPublished by Elsevier ,1996
- Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in miceLife Sciences, 1993
- Effect of murine recombinant interleukin-5 on bronchial reactivity in guinea-pigsClinical and Experimental Allergy, 1993
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- The eosinophil and bronchial asthma: Current understandingJournal of Allergy and Clinical Immunology, 1990
- Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophilsJournal of Allergy and Clinical Immunology, 1988